Similar articles

• PSA screening for prostate cancer: the current controversy.

  de Koning HJ, Schröder FH. de Koning HJ, et al. Ann Oncol. 1998 Dec;9(12):1293-6. doi: 10.1023/a:1008428327309. Ann Oncol. 1998. PMID: 9932158 Review. No abstract available.
• PSA screening--current controversy.

  Svetec D, Thompson IM. Svetec D, et al. Ann Oncol. 1998 Dec;9(12):1283-8. doi: 10.1023/a:1008446208963. Ann Oncol. 1998. PMID: 9932156 Review.
• PSA screening for prostate cancer: the current controversy--a viewpoint. Patient Outcomes Research Team for Prostatic Diseases.

  Barry MJ. Barry MJ. Ann Oncol. 1998 Dec;9(12):1279-82. doi: 10.1093/oxfordjournals.annonc.a010952. Ann Oncol. 1998. PMID: 9932155 Review.
• Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.

  Boyle P. Boyle P. Ann Oncol. 1998 Dec;9(12):1263-4. doi: 10.1023/a:1008435911379. Ann Oncol. 1998. PMID: 9932152 No abstract available.
• Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study.

  Zappa M, Ciatto S, Bonardi R, Mazzotta A. Zappa M, et al. Ann Oncol. 1998 Dec;9(12):1297-300. doi: 10.1023/a:1008492013196. Ann Oncol. 1998. PMID: 9932159